New JTH Research on Bleeding Risk in Pregnant Women Treated for Acute Venous Thromboembolism
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn:
“The risk of bleeding in pregnant women with acute venous thromboembolism treated with anticoagulants: an international multidatabase cohort study
This multinational study assessed bleeding risk in pregnant women treated with low-molecular-weight heparins (LMWH) for acute VTE. It found no significant difference in bleeding risk between LMWH types or dosing schedules, highlighting the need for further research to optimize anticoagulation care in pregnancy.”
Title: The risk of bleeding in pregnant women with acute venous thromboembolism treated with anticoagulants: an international multidatabase cohort study
Authors: Camille Simard, Isabelle Malhamé, Christopher Filliter, Annika Vivirito, Kristian B. Filion, Haim Abenhaim, Dirk Enders, Antonios Douros, Vicky Tagalakis
Read the full article here.
Find similar posts on Hemostasis Today.
-
Dec 17, 2025, 15:24Laura Dormer on a Motor Relearning Program for Chronic Stroke Patients
-
Dec 17, 2025, 15:01WSO: United Nations Has Formally Adopted the Political Declaration on NCDs and Mental Health
-
Dec 17, 2025, 14:44Bryan Unger: 1st Patient Has Been Enrolled in NuvOx Therapeutics’ Phase IIb NOVEL Trial
-
Dec 17, 2025, 14:29Sarah Richardson: Feeling So Proud to Be a Part of the Advocacy Team for the HFA
-
Dec 17, 2025, 06:28Wolfgang Miesbach on Linus Völker’s Presentation of Caplacizumab as Frontline Therapy for iTTP
-
Dec 17, 2025, 06:11Lisa Murphy Thanks Stroke Foundation Team for An Impactful, Rewarding and Incredible Year
-
Dec 17, 2025, 06:05Emmanuel J Favaloro Shares A Study on AI and Machine Learning in Thrombosis and Hemostasis
-
Dec 17, 2025, 05:54Michael Bruckman: Fantastic to See Platelet-Inspired Nanoparticles Gaining Attention!
-
Dec 17, 2025, 04:00Peter Verhamme on Genetic Predisposition to Thromboembolism and COVID